Chronic Lung Disease of Prematurity Completed Phase 3 Trials for Inosine (DB04335)

Also known as: Bronchopulmonary Dysplasia / Dysplasia, Bronchopulmonary / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00006401Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature InfantsPrevention